Mylan recalls 150 mcg levothyroxine tablets due to potential subpotent or superpotent drug levels. This may cause ineffective treatment or adverse effects. Check NDC 51079-445-20 for affected lots.
Subpotent and Superpotent Drug
Mylan is recalling levothyroxine sodium tablets that may contain incorrect drug strength, which could lead to ineffective treatment or harmful side effects. This recall affects patients taking this medication as prescribed.
The tablets may have subpotent (too weak) or superpotent (too strong) drug levels, which can cause the medication to be ineffective or cause adverse effects. This happens because the drug concentration is not within the intended therapeutic range.
Patients prescribed levothyroxine sodium tablets by a healthcare provider. Those with thyroid conditions are most at risk if the medication is not properly dosed.
Check for the NDC code 51079-445-20 on the packaging. The lot number 3115924 was produced with an expiration date of June 2025. These tablets are prescription-only and sold in cartons of 100 tablets.
Verify the NDC code 51079-445-20 and lot number 3115924 on the packaging.
The recall is for potential subpotent or superpotent drug levels, which could lead to ineffective treatment or adverse effects, but it does not indicate immediate risk of serious injury.
Check for the NDC code 51079-445-20 and lot number 3115924 on the packaging. These tablets are prescription-only and sold in cartons of 100 tablets.
The recall does not specify a remedy, so contact your healthcare provider for guidance on whether to continue using the medication.
We’ve drafted a message you can send Mylan to request your refund or repair — edit it as you like.
Subject: Recall D-0135-2025 — Mylan Mylan Hello, I own a Mylan that is covered by recall D-0135-2025 from Mylan. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
